Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Insights into side effects of thalidomide using magnetic nanoprobes

05.03.2012
Tokyo Tech’s Hiroshi Handa and colleagues have identified a key protein— cereblon —that plays a key role in the development of birth defects associated with thalidomide using unique sub-micrometer functionalized magnetic nanobeads.
The discovery opens up possibilities for the development of alternative and safer drugs for the treatment of multiple myeloma and leprosy.
Hiroshi Hanada describes his research on magnetic particles for biomedicine in a video interview in the latest Feb 2012 issue of Tokyo Tech’s on line newsletter the Tokyo Tech Bulletin: http://www.titech.ac.jp/bulletin/

Details about Hiroshi Handa’s report on the ‘Identification of a Primary Target of Thalidomide Teratogenicity’ published in Science 327, 1345 (2010).

Thalidomide was prescribed as a sedative for pregnant women to treat morning sickness in the late 1950s. It was removed from the market in the early 1960s, when its use was linked to birth defects including shortened or absent limbs, as well as ear, cardiac and gastrointestinal malformations. However, within a few years the powerful pain relief properties of thalidomide for leprosy patients suggested that the drug may yet have medical benefits. In the 1990s it was also proven to be effective in the treatment of the cancer multiple myeloma.

It is still little understood how use of thalidomide leads to the development of birth defects, and tight restrictions are maintained over administration of the drug to treat leprosy and cancer. Insights into the mechanism behind the toxic effects of thalidomide on pregnant women could help to find ways to avoid these side effects and release the potential of the drug as a powerful medical aid.

Researchers at Tokyo Tech have recently reported the development of high-performance affinity beads – magnetic beads 200 nm in diameter that can be attached to drugs and other compounds, allowing one-step affinity purification of drug targets and an insight into how the drugs act [1]. As Hiroshi Handa and his colleagues explain, “Currently, most commercially available drugs and physiologically active substances have been brought to market without knowledge of factors interacting with the drugs and the substances.” Handa have now applied the beads to unravelling the mystery behind the birth defects caused by thalidomide [2].

The researchers used ferrite glycidyl methacrylate beads for purity affiliation of thalidomide, and identified cereblon as a protein that binds directly with the drug. The researchers then performed in vivo experiments in zebrafish, which were recently shown to be affected by thalidomide during embryonic development and have the useful attribute of a transparent embryo so that the progress of development can be conveniently monitored. Knockdown of genes of interest is also easily implemented in zebrafish. Thalidomide treatment was found to noticeably affect the development of the pectoral fins and otic vesicles, which it is suggested, share common molecular pathways with that of developing limbs and ears in tetrapods.

Zebrafish have a gene that is orthologously similar to cereblon in humans. The researchers investigated the development of embryos in which this gene was knocked down and similar defects were observed as for embryos treated with thalidomide. Co-injection of messenger RNA for the cereblon-orthologous gene was found to rescue these defects. The results suggest a potential means to reverse the developmental problems caused by thalidomide treatment.

The researchers then investigated the role of cereblon in chicks, which are well-established model organisms for studying thalidomide-induced birth defects. Experiments on chicks further supported the conclusion that cereblon is a direct target in thalidomide-induced birth defects.

The action of thalidomide is complex and it is associated with a number of other mechanisms that may also cause problems in fetal development, including oxidative stress and antiangiogenic activity. However, as Handa and his colleagues explain, “identification of thalidomide’s direct target may allow rational design of more effective thalidomide derivatives without teratogenic activity”. The work holds promise for a role of thalidomide in medical treatment that is not blighted by the side effects observed in the past.

References:
[1] T. Ito, H. Ando, T. Suzuki, T. Ogura, K. Hotta,Y. Imamura, Y. Yamaguchi & H. Handa. “Identification of a Primary Target of Thalidomide Teratogenicity,” Science 327, 1345 (2010).
[2]S. Sakamoto, Y. Kabe, M. Hatakeyama, Y. Yamaguchi, & H. Handa. “Development and application of high-performance affinity beads: Toward chemical biology and drug discovery,” The Chemical Record 9, 66-85 (2009).

Further information:
Hidekazu Ueda and Yukiko Tokida
Center for Public Information
Tokyo Institute of Technology
2-12-1, Ookayama, Meguro-ku, Tokyo 152-8550, Japan
E-mail: kouhou@jim.titech.ac.jp
URL: http://www.titech.ac.jp/english/
Tel: +81-3-5734-2975
Fax: +81-3-5734-3661
About Tokyo Institute of Technology
As one of Japan’s top universities, Tokyo Institute of Technology seeks to contribute to civilization, peace and prosperity in the world, and aims at developing global human capabilities par excellence through pioneering research and education in science and technology, including industrial and social management. To achieve this mission, we have an eye on educating highly moral students to acquire not only scientific expertise but also expertise in the liberal arts, and a balanced knowledge of the social sciences and humanities, all while researching deeply from basics to practice with academic mastery. Through these activities, we wish to contribute to global sustainability of the natural world and the support of human life.

Website: http://www.titech.ac.jp/english/

Hidekazu Ueda | Tokyo Institute of Technology
Further information:
http://www.titech.ac.jp/english/

More articles from Life Sciences:

nachricht Navigational view of the brain thanks to powerful X-rays
18.10.2017 | Georgia Institute of Technology

nachricht Separating methane and CO2 will become more efficient
18.10.2017 | KU Leuven

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Osaka university researchers make the slipperiest surfaces adhesive

18.10.2017 | Materials Sciences

Space radiation won't stop NASA's human exploration

18.10.2017 | Physics and Astronomy

Los Alamos researchers and supercomputers help interpret the latest LIGO findings

18.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>